Ultrapure water for pharmaceutical manufacturing FAQs
The role of ultrapure water in pharmaceutical manufacturing
Water quality is critical to pharmaceutical manufacturing, where purity, consistency, and regulatory compliance are essential to patient safety and process performance. We've answered some of the most frequently asked questions about ultrapure water, including the different water grades and the role ultrapure water systems play in ensuring reliable, compliant water production.
Frequently asked questions
- Purified water (PW): Used in general pharmaceutical manufacturing, cleaning, and formulation
- Water for injection (WFI): The highest purity grade, used for injectable products and critical processes
- Sterile water for injection (SWFI): WFI that has been sterilised and packaged for clinical use
- Bacteriostatic water for injection: Contains antimicrobial agents to inhibit bacterial growth in multi-dose applications
These defined water types are produced using advanced purification processes, including ultrapure water (UPW) systems, to ensure consistent quality and compliance.
No, while both are highly purified, ultrapure water (UPW) refers to the treatment and production process, whereas sterile water refers to the final application and sterility requirements.
UPW systems are used to produce pharmaceutical-grade water, including PW and WFI, ensuring consistent quality and compliance.
UPW systems form the foundation of pharmaceutical water production, enabling consistent, high-quality generation of PW and WFI in line with global standards.
Water for injection (WFI) is produced using advanced purification processes designed to meet strict pharmaceutical standards for microbial and endotoxin control.
Traditionally, WFI has been produced through distillation, which ensures the removal of impurities, bacteria, and endotoxins. However, modern systems increasingly use membrane-based technologies, such as reverse osmosis (RO), continuous electrodeionisation (CEDI) and UV treatment, in combination to achieve the required purity.
These processes are carefully designed, validated, and continuously monitored to ensure consistent water quality in line with global pharmacopeia standards.
Ionpure's LX-HI modules are specifically designed to undergo hot water sanitisation at the specified maximum temperature without requiring a temperature ramp-up. This can simplify sanitisation procedures, reduce downtime, and help operators achieve sanitisation conditions more quickly while maintaining the high-water quality required for pharmaceutical ultrapure water (UPW), water for injection (WFI), and sterile water for injection (SWFI) applications.
Hot water sanitization helps maintain microbiological control throughout the ultrapure water (UPW) system without the routine use of chemicals. Regular exposure of the system to elevated temperatures reduces the risk of bacterial growth and biofilm formation, supporting consistent water quality and regulatory compliance.
Ionpure's LX-HI CEDI modules are designed for periodic hot water sanitization at temperatures 85°C +/- 5°C and continuous operation up to 60 C, to provide reliable microbial control to ensure the high water quality required for the production of water for sterile water for injection (SWFI).